test

About

The TuBerculosis Vaccine Initiative (TBVI) is a Research and Innovation partnership that works to discover and develop new, safe and effective TB vaccines that are accessible and affordable for all people.

News

Announcement Awardees | TBVI Awards 2026

Phase 1b/2a clinical trial in adults of novel TB vaccine candidate MTBVAC shows promising results

Announcement TBVI Awards 2026

Email

info@tbvi.eu

Phone

+31 (0) 6 1099 5196

Address

Runderweg 6
8219 PK Lelystad